Exploratory chemistry and HIT-to-lead chemistry option. Medicinal chemistry support program for therapeutic development (mcsp). POP: september 21, 2026 to march 20, 2029. DAP-ncap-00000137
Active Awarded Last action
- Contract number
- 75N98026F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,138,209
Award facts
- Opportunity
-
- NINDS2601 Solicitation number
- Contract value 56% obligated
-
- $2,138,209.31 Current, with exercised options
- $3,819,498.94 Potential, with all options
- Completion date 4% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Neurological Disorders and Stroke issued a delivery order to Curia Global Inc. (doing business as Amri) on September 21, 2026, with a ceiling value of $3.8 million for exploratory and hit-to-lead medicinal chemistry support under the Medicinal Chemistry Support Program for Therapeutic Development (MCSP).
Performance runs from September 21, 2026 through March 20, 2029, in Albany, NY. The order is priced on a cost-plus-fixed-fee basis and carries no set-aside designation. Curia Global Inc. is a contract development and manufacturing organization specializing in pharmaceutical research and development services, with extensive prior delivery orders and purchase orders from NIH institutes including NINDS, NIAID, NCATS, and NIDA across therapeutic areas including neurology, infectious diseases, and substance abuse.
Quick answers
Who was awarded contract 75N98026F00001?
75N98026F00001 was awarded to Curia Global Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 21, 2026.
How much is contract 75N98026F00001 worth?
The government has obligated $2,138,209 on 75N98026F00001. Its potential value, with all options, is $3,819,499.
Which agency awarded contract 75N98026F00001?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N98026F00001 an order under another contract?
Yes. 75N98026F00001 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N98026F00001 competed?
The extent of competition for 75N98026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award